BioCentury
ARTICLE | Clinical News

Sublinox: Phase III data

October 8, 2007 7:00 AM UTC

In a double-blind, international Phase III trial in 73 patients, 10 mg of Sublinox induced sleep 30% more rapidly than a 10 mg dose of Ambien, which ORX said met the study's primary endpoint. Ambien ...